Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Carrie E. Ryan(University at Buffalo, State University of New York), Heloisa P. Soares(University of Utah), Areeba Saif(National Institutes of Health), Flavio G. Rocha(Oregon Health & Science University), Syed A. Ahmad(University of Cincinnati), Philip Philip(Wayne State University), Jonathan M. Hernandez(National Institutes of Health)
Cited by 3
Related Papers
Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
|PLoS ONE|2013|129
Assessing the Need for a Standardized Cancer HUman Biobank (caHUB): Findings From a National Survey With Cancer Researchers
|JNCI Monographs|2011|62
Transthoracic Anastomotic Leak After Esophagectomy: Current Trends
|Annals of Surgical Oncology|2016|53
Distal Pancreatectomy and Splenectomy: A Robotic or LESS Approach
|JSLS Journal of the Society of Laparoscopic & Robotic Surgeons|2015|45